Secondary Logo

Journal Logo

Most Popular Articles

Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

Stephan, Christoph; Wolf, Timo; Goetsch, Udo; More

AIDS. 22(18):2471-2479, November 30, 2008.

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

Cutrell, Amy G.; Schapiro, Jonathan M.; Perno, Carlo F.; More

AIDS. 35(9):1333-1342, July 15, 2021.

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1

Ackerman, Peter; Thompson, Melanie; Molina, Jean-Michel; More

AIDS. 35(7):1061-1072, June 1, 2021.

Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine

Meza, Giovanna; Expósito, Almudena; Royo, José L.; More

AIDS. 34(1):25-32, January 1, 2020.

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen

Keene, Claire M.; Griesel, Rulan; Zhao, Ying; More

AIDS. 35(9):1423-1432, July 15, 2021.

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Gupta, Samir K.; Post, Frank A.; Arribas, José R.; More

AIDS. 33(9):1455-1465, July 15, 2019.

Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy

Fleming, Julia; Mathews, W. Christopher; Rutstein, Richard M.; More

AIDS. 33(13):2005-2012, November 1, 2019.

Clinic and care: associations with adolescent antiretroviral therapy adherence in a prospective cohort in South Africa

Cluver, Lucie; Shenderovich, Yulia; Toska, Elona; More

AIDS. 35(8):1263-1271, July 1, 2021.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

May, Margaret T.; Gompels, Mark; Delpech, Valerie; More

AIDS. 28(8):1193-1202, May 15, 2014.

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis

Molloy, Síle F.; Bradley, John; Karunaharan, Natasha; More

AIDS. 32(15):2259-2261, September 24, 2018.

Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection

Ortega, Paula A.S.; Saulle, Irma; Mercurio, Vincenzo; More

AIDS. 32(17):2453-2461, November 13, 2018.

Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa

Woldesenbet, Selamawit A.; Kufa, Tendesayi; Barron, Peter; More

AIDS. 34(4):589-597, March 15, 2020.

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Leal, Lorna; Guardo, Alberto C.; Morón-López, Sara; More

AIDS. 32(17):2533-2545, November 13, 2018.

Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa

Stoner, Marie C.D.; Nguyen, Nadia; Kilburn, Kelly; More

AIDS. 33(1):83-91, January 2, 2019.

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation

Bull, Marta E.; Mitchell, Caroline; Soria, Jaime; More

AIDS. 32(11):1389-1401, July 17, 2018.

Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth

Brumme, Zabrina L.; Sudderuddin, Hanwei; Ziemniak, Carrie; More

AIDS. 33(2):211-218, February 1, 2019.

The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa

Stangl, Anne L.; Pliakas, Triantafyllos; Mainga, Tila; More

AIDS. 34(14):2125-2135, November 15, 2020.

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV

Burns, James E.; Stirrup, Oliver T.; Dunn, David; More

AIDS. 34(1):109-114, January 1, 2020.

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure

Shroufi, Amir; Van Cutsem, Gilles; Cambiano, Valentina; More

AIDS. 33(10):1635-1644, August 1, 2019.

Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial

Kamwesiga, Julius; Mutabazi, Vincent; Kayumba, Josephine; More

AIDS. 29(9):1045-1052, June 1, 2015.

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

Van Gulck, Ellen; Vlieghe, Erika; Vekemans, Marc; More

AIDS. 26(4):F1-F12, February 20, 2012.

The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide

Friedland, Barbara A.; Gottert, Ann; Hows, Julian; More

AIDS. 34:S5-S18, September 1, 2020.

Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

De Francesco, Davide; Wit, Ferdinand W.; Bürkle, Alexander; More

AIDS. 33(2):259-268, February 1, 2019.

The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability

Marston, Milly; Nakiyingi-Miiro, Jessica; Kusemererwa, Sylvia; More

AIDS. 31:S69-S76, April 2017.

Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program

Hickey, Matthew D.; Imbert, Elizabeth; Glidden, David V.; More

AIDS. 35(3):517-519, March 1, 2021.

C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa

Shapiro, Adrienne E.; Hong, Ting; Govere, Sabina; More

AIDS. 32(13):1811-1820, August 24, 2018.

Interventions to reduce gender-based violence among young people living with or affected by HIV/AIDS in low-income and middle-income countries

Meinck, Franziska; Pantelic, Marija; Spreckelsen, Thees F.; More

AIDS. 33(14):2219-2236, November 15, 2019.

Show: